Grand Pharmaceutical GroupCGPHF 87 Days Payable is 104.18 as of Dec. 2025, which is 1% above its 10-year median of 103.31. GuruFocus rates CGPHF with a GF Score™ of 87/100. The stock has 6 warning signs investors should review. Among 920 Drug Manufacturers companies, Grand Pharmaceutical Group ranks better than 56.52% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Grand Pharmaceutical Group's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Grand Pharmaceutical Group Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Grand Pharmaceutical Group's Days Payable distribution charts can be found below:
* The bar in red indicates where Grand Pharmaceutical Group's Days Payable falls into.
Grand Pharmaceutical Group Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Grand Pharmaceutical Group (CGPHF) has a Days Payable of 104.18 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Grand Pharmaceutical Group and its competitors. This is near median its historical median of 103.31. Over the past decade, Grand Pharmaceutical Group's Days Payable has ranged from 76.09 to 135.32. According to the industry distribution chart, Grand Pharmaceutical Group ranks #400 out of 920 companies in the Drug Manufacturers industry, placing it in the top 43.5%.
Is Grand Pharmaceutical Group's Days Payable too high?
Grand Pharmaceutical Group's current Days Payable of 104.18 is near median its 10-year median of 103.31. Over the past 10 years, this metric has ranged from a low of 76.09 to a high of 135.32. The Drug Manufacturers industry median Days Payable is 90.84. Grand Pharmaceutical Group's value of 104.18 is 14.7% above this industry median. Based on the distribution chart, Grand Pharmaceutical Group ranks #400 out of 920 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Grand Pharmaceutical Group has a GF Score™ of 87/100, reflecting its overall financial health beyond just this single metric.
How does Grand Pharmaceutical Group's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Grand Pharmaceutical Group ranks #400 out of 920 companies for Days Payable. This puts Grand Pharmaceutical Group in the upper half of its industry. The industry median Days Payable is 90.84. Grand Pharmaceutical Group's value of 104.18 is 14.7% above this benchmark. Historically, Grand Pharmaceutical Group's own Days Payable has ranged from 76.09 to 135.32 over the past decade. While the company's 10-year median is 103.31 vs. the industry median of 90.84, Grand Pharmaceutical Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.84, based on 920 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Grand Pharmaceutical Group's current Days Payable of 104.18 is 14.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Grand Pharmaceutical Group and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Grand Pharmaceutical Group's current Days Payable is 104.18, which is near median its own 10-year median of 103.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grand Pharmaceutical Group stock overvalued right now?
Grand Pharmaceutical Group (CGPHF) has a current Days Payable of 104.18. The current Days Payable is 104.18, which is near median its 10-year median of 103.31 and 14.7% above the Drug Manufacturers industry median of 90.84. Grand Pharmaceutical Group's overall GF Score™ is 87/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Grand Pharmaceutical Group (CGPHF), the current Days Payable is 104.18 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Grand Pharmaceutical Group Ltd are principally engaged in the manufacture and sales of pharmaceutical technology products, manufacture and sales of bio-technology products as well as manufacture and sales of nuclear medicine anti-tumor diagnosis and treatment and cerebro-cardiovascular precision interventional diagnosis and treatment technology products, in the People's Republic of China. The operation of the group constitutes one single reportable segment. The company has presence in The PRC, America, Europe, Asia other than the PRC and Others. The majority of revenue comes from the PRC. Its brands are breathe, biology, Cardiovascular emergency care, Cardiovascular intervention, ENT, tumor.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CGPHF has been successfully added to your 